65.45
-0.80
(-1.21%)
At close: 5:35:50 PM GMT+1
Breakdown
TTM
11/30/2023
11/30/2022
11/30/2021
11/30/2020
Total Revenue
2,012,200.00
1,990,486.00
1,817,094.00
1,498,007.00
1,418,786.00
Cost of Revenue
1,426,800.00
1,393,172.00
1,270,282.00
1,051,685.00
981,181.00
Gross Profit
585,400.00
597,314.00
546,812.00
446,322.00
437,605.00
Operating Expense
364,320.00
367,854.00
353,100.00
256,934.00
256,777.00
Operating Income
221,080.00
229,460.00
193,712.00
189,388.00
180,828.00
Net Non Operating Interest Income Expense
-47,873.00
-45,962.00
-28,502.00
-19,576.00
-21,316.00
Pretax Income
157,138.00
167,429.00
140,811.00
127,865.00
135,145.00
Tax Provision
40,830.00
47,344.00
38,620.00
40,624.00
45,264.00
Net Income Common Stockholders
114,296.00
116,126.00
96,120.00
83,788.00
88,559.00
Diluted NI Available to Com Stockholders
114,296.00
116,126.00
96,120.00
83,788.00
88,559.00
Basic EPS
3.32
3.48
3.06
2.67
2.82
Diluted EPS
3.32
3.48
3.06
2.67
2.82
Basic Average Shares
34,539.00
33,336.00
31,400.00
31,400.00
31,400.00
Diluted Average Shares
34,539.00
33,336.00
31,400.00
31,400.00
31,400.00
Total Operating Income as Reported
205,011.00
213,391.00
169,313.00
147,441.00
156,461.00
Total Expenses
1,791,120.00
1,761,026.00
1,623,382.00
1,308,619.00
1,237,958.00
Net Income from Continuing & Discontinued Operation
114,296.00
116,126.00
96,120.00
83,788.00
88,559.00
Normalized Income
125,015.07
126,509.59
113,483.02
111,996.20
103,895.90
Interest Income
4,078.00
3,802.00
1,984.00
1,326.00
1,455.00
Interest Expense
55,886.00
50,435.00
27,955.00
20,702.00
20,763.00
Net Interest Income
-47,873.00
-45,962.00
-28,502.00
-19,576.00
-21,316.00
EBIT
213,024.00
217,864.00
168,766.00
148,567.00
155,908.00
EBITDA
407,347.00
403,890.00
340,321.00
293,926.00
301,411.00
Reconciled Cost of Revenue
1,426,800.00
1,393,172.00
1,270,282.00
1,051,685.00
981,181.00
Reconciled Depreciation
194,323.00
186,026.00
171,555.00
145,359.00
145,503.00
Net Income from Continuing Operation Net Minority Interest
114,296.00
116,126.00
96,120.00
83,788.00
88,559.00
Total Unusual Items Excluding Goodwill
-14,482.00
-14,482.00
-23,916.00
-41,361.00
-23,063.00
Total Unusual Items
-14,482.00
-14,482.00
-23,916.00
-41,361.00
-23,063.00
Normalized EBITDA
421,829.00
418,372.00
364,237.00
335,287.00
324,474.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-3,762.93
-4,098.41
-6,552.98
-13,152.80
-7,726.11
11/30/2020 - 6/11/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1SXP.DE SCHOTT Pharma AG & Co. KGaA
24.38
-2.56%
BOX.DE Becton, Dickinson and Company
228.00
-1.38%
BIG1.DE Bio-Gate AG
0.7400
0.00%
IUI1.DE Intuitive Surgical, Inc.
527.10
+1.05%
COLOBc.XC
56S1.DE Sartorius Stedim Biotech S.A.
206.00
+3.23%
1SXP.VI SCHOTT Pharma AG & Co. KGaA
24.38
-2.40%
AFX.DE Carl Zeiss Meditec AG
44.90
-3.69%
SRT3.BE Sartorius AG
244.20
+4.36%
SKANz.XC